CN102526399A - Chinese medicine preparation for treating chronic pelvic inflammation - Google Patents
Chinese medicine preparation for treating chronic pelvic inflammation Download PDFInfo
- Publication number
- CN102526399A CN102526399A CN2012100228413A CN201210022841A CN102526399A CN 102526399 A CN102526399 A CN 102526399A CN 2012100228413 A CN2012100228413 A CN 2012100228413A CN 201210022841 A CN201210022841 A CN 201210022841A CN 102526399 A CN102526399 A CN 102526399A
- Authority
- CN
- China
- Prior art keywords
- radix
- chinese medicine
- radix angelicae
- medicine preparation
- rhizoma
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title claims abstract description 50
- 238000002360 preparation method Methods 0.000 title claims abstract description 29
- 208000029082 Pelvic Inflammatory Disease Diseases 0.000 title claims abstract description 26
- 230000001684 chronic effect Effects 0.000 title claims abstract description 24
- 229940079593 drug Drugs 0.000 claims abstract description 21
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims abstract description 14
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 14
- 235000008434 ginseng Nutrition 0.000 claims abstract description 14
- 238000000034 method Methods 0.000 claims abstract description 13
- 241000208340 Araliaceae Species 0.000 claims description 13
- 241000628997 Flos Species 0.000 claims description 13
- 239000009636 Huang Qi Substances 0.000 claims description 13
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims description 13
- 239000009286 sanguis draxonis Substances 0.000 claims description 13
- 239000000203 mixture Substances 0.000 claims description 8
- 239000000843 powder Substances 0.000 abstract description 12
- 230000000694 effects Effects 0.000 abstract description 9
- 239000002775 capsule Substances 0.000 abstract description 3
- 239000006187 pill Substances 0.000 abstract description 3
- 239000002994 raw material Substances 0.000 abstract 2
- 241000382455 Angelica sinensis Species 0.000 abstract 1
- 241000045403 Astragalus propinquus Species 0.000 abstract 1
- 241000207925 Leonurus Species 0.000 abstract 1
- 244000131316 Panax pseudoginseng Species 0.000 abstract 1
- 241001522129 Pinellia Species 0.000 abstract 1
- 244000197580 Poria cocos Species 0.000 abstract 1
- 235000008599 Poria cocos Nutrition 0.000 abstract 1
- 241001180876 Saposhnikovia Species 0.000 abstract 1
- 240000001638 Scurrula parasitica Species 0.000 abstract 1
- 240000004824 Trimezia steyermarkii Species 0.000 abstract 1
- 235000006533 astragalus Nutrition 0.000 abstract 1
- 239000009136 dragon's blood Substances 0.000 abstract 1
- 239000008187 granular material Substances 0.000 abstract 1
- 238000012216 screening Methods 0.000 abstract 1
- 239000003826 tablet Substances 0.000 abstract 1
- 231100000331 toxic Toxicity 0.000 abstract 1
- 230000002588 toxic effect Effects 0.000 abstract 1
- 230000002757 inflammatory effect Effects 0.000 description 8
- 208000024891 symptom Diseases 0.000 description 4
- 230000001225 therapeutic effect Effects 0.000 description 4
- 210000004291 uterus Anatomy 0.000 description 4
- 230000002146 bilateral effect Effects 0.000 description 3
- 230000003115 biocidal effect Effects 0.000 description 3
- 230000003203 everyday effect Effects 0.000 description 3
- 210000000416 exudates and transudate Anatomy 0.000 description 3
- 210000003101 oviduct Anatomy 0.000 description 3
- 241000521257 Hydrops Species 0.000 description 2
- 208000019255 Menstrual disease Diseases 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 239000002260 anti-inflammatory agent Substances 0.000 description 2
- 229940124599 anti-inflammatory drug Drugs 0.000 description 2
- 231100000957 no side effect Toxicity 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 206010014568 Empyema Diseases 0.000 description 1
- 240000004859 Gamochaeta purpurea Species 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010067482 No adverse event Diseases 0.000 description 1
- 206010057071 Rectal tenesmus Diseases 0.000 description 1
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 210000003679 cervix uteri Anatomy 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- -1 electuary Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 210000004392 genitalia Anatomy 0.000 description 1
- 210000003714 granulocyte Anatomy 0.000 description 1
- 208000021267 infertility disease Diseases 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 230000003448 neutrophilic effect Effects 0.000 description 1
- 210000001672 ovary Anatomy 0.000 description 1
- 210000004303 peritoneum Anatomy 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 208000037920 primary disease Diseases 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 208000012271 tenesmus Diseases 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Abstract
The invention discloses a Chinese medicine preparation for treating chronic pelvic inflammation, which is proved by years' clinic application that the Chinese medicine preparation has a total effective rate above 90%, and is good in curative effect and free of toxic and side effects. The Chinese medicine preparation is composed of the following raw material medicines: angelica sinensis 20-30g, poria cocos 20-30g, leonurus 20-30g, notopterygium root 15-25g, red flower 15-25g, dragon's blood 15-25g, radix angelicae 15-25g, rhizoma atractylodis macrocephalae 15-25g, radix paeoniae rubra 10-20g, loranthus parasiticus 10-20g, cortex acanthopanacis 10-20g, divaricate saposhnikovia root 5-15g, astragalus mongholicus 5-15g, ginseng 5-15g, pinellia ternate 5-15g and radix angelicae pubescentis 5-15g. A preparing method is taking each raw material medicine, crushing the medicines into powder, screening the medicines through a 200-mesh screen, mixing and preparing into powder, capsules, granules, tablets and pills, and then obtaining the Chinese medicine preparation. During treatment, a patient orally takes the preparation one time at morning and night with amount of 5g or so each time, fifteen days form one course of the treatment, and generally the chronic pelvic inflammation can be cured in 2-5 courses of the treatment.
Description
Technical field
The present invention relates to a kind of Chinese medicine preparation of treating chronic pelvic inflammatory disease.
Background technology
Female internal genital organs (uterus, ovary, fallopian tube) and tissue on every side, pelvic cavity, be called pelvic inflammatory disease when peritoneum is inflamed, chronic pelvic inflammatory disease is that acute pelvic inflammatory disease fails thoroughly to cure or sick the kind due to the delay, when Abwehrkraft des Koepers is relatively poor, can show effect.Chronic pelvic inflammatory disease has hypogastric region dull pain and tenesmus, with lumbosacral aching pain, leucorrhoea grow in quantity, menoxenia.Gynecologial examination can touch inflammatory mass in various degree at pelvic cavity, brings very big inconvenience to patient's work and life.At present; It is main that the treatment primary disease adopts the antibiosis anti-inflammatory drug of doctor trained in Western medicine more; Though the state of an illness is control to some extent temporarily, is prone to recurrence, and the antibiosis anti-inflammatory drug of doctor trained in Western medicine has great harm to liver, the kidney of human body; The administration time elder also might cause other complication, and there is problem such as cost an arm and a leg, drug treatment is long, produce effects slowly in the doctor trained in Western medicine antibiotic medicine.
Summary of the invention
To above-mentioned prior art, the invention provides a kind of Chinese medicine preparation of treating chronic pelvic inflammatory disease, its therapeutic effect is good, and cost is low, has no side effect short treating period.
The present invention realizes through following technical scheme:
A kind of Chinese medicine preparation of treating chronic pelvic inflammatory disease is made up of following crude drug: Radix Angelicae Sinensis 20～30g, Poria 20～30g, Herba Leonuri 20～30g, Rhizoma Et Radix Notopterygii 15～25g; Flos Carthami 15～25g, Sanguis Draxonis 15～25g, the Radix Angelicae Dahuricae 15～25g, the Rhizoma Atractylodis Macrocephalae 15～25g; Radix Paeoniae Rubra 10～20g, Herba Taxilli 10～20g, Cortex Acanthopancis 10～20g, windproof 5～15g; The Radix Astragali 5～15g, Radix Ginseng 5～15g, the Rhizoma Pinelliae 5～15g, Radix Angelicae Pubescentis 5～15g.
Preferably, form: Radix Angelicae Sinensis 25g, Poria 25g, Herba Leonuri 25g, Rhizoma Et Radix Notopterygii 20g, Flos Carthami 20g by following crude drug; Sanguis Draxonis 20g, Radix Angelicae Dahuricae 20g, Rhizoma Atractylodis Macrocephalae 20g, Radix Paeoniae Rubra 15g, Herba Taxilli 15g, Cortex Acanthopancis 15g; Windproof 10g, Radix Astragali 10g, Radix Ginseng 10g, Rhizoma Pinelliae 10g, Radix Angelicae Pubescentis 10g.
Preferably, form: Radix Angelicae Sinensis 22g, Poria 22g, Herba Leonuri 28g, Rhizoma Et Radix Notopterygii 23g, Flos Carthami 18g by following crude drug; Sanguis Draxonis 18g, Radix Angelicae Dahuricae 23g, Rhizoma Atractylodis Macrocephalae 23g, Radix Paeoniae Rubra 12g, Herba Taxilli 12g, Cortex Acanthopancis 18g; Windproof 13g, Radix Astragali 8g, Radix Ginseng 8g, Rhizoma Pinelliae 13g, Radix Angelicae Pubescentis 13g.
Preferably, form: Radix Angelicae Sinensis 28g, Poria 28g, Herba Leonuri 22g, Rhizoma Et Radix Notopterygii 18g, Flos Carthami 23g by following crude drug; Sanguis Draxonis 23g, Radix Angelicae Dahuricae 18g, Rhizoma Atractylodis Macrocephalae 18g, Radix Paeoniae Rubra 18g, Herba Taxilli 18g, Cortex Acanthopancis 12g; Windproof 8g, Radix Astragali 13g, Radix Ginseng 13g, Rhizoma Pinelliae 8g, Radix Angelicae Pubescentis 8g.
The method for preparing of the Chinese medicine preparation of said treatment chronic pelvic inflammatory disease is: get each crude drug, pulverize and be powdery, cross 200 mesh sieves, mix, process powder, capsule, electuary, tablet or pill, promptly get.
The Chinese medicine preparation of treatment chronic pelvic inflammatory disease of the present invention cures mainly chronic pelvic inflammatory disease, and is oral during treatment, and each was once taken about 5g at every turn and (pressed the medicated powder Mass Calculation) sooner or later every day, and 15 days is a course of treatment, and can cure general 2～5 courses of treatment.
The Chinese medicine preparation of treatment chronic pelvic inflammatory disease of the present invention, the prescription scientific and precise, specific aim is more intense, and therapeutic effect is good, and through clinical application for many years, total effective rate is more than 90%, and curative effect is very good, and has no side effect.
The specific embodiment
Below in conjunction with embodiment and clinical data the present invention is further described.
A kind of Chinese medicine preparation of treating chronic pelvic inflammatory disease of embodiment 1 preparation
Prescription is: Radix Angelicae Sinensis 25g, Poria 25g, Herba Leonuri 25g, Rhizoma Et Radix Notopterygii 20g, Flos Carthami 20g, Sanguis Draxonis 20g, Radix Angelicae Dahuricae 20g, Rhizoma Atractylodis Macrocephalae 20g, Radix Paeoniae Rubra 15g, Herba Taxilli 15g, Cortex Acanthopancis 15g, windproof 10g, Radix Astragali 10g, Radix Ginseng 10g, Rhizoma Pinelliae 10g, Radix Angelicae Pubescentis 10g.
Method for preparing is: get each crude drug, pulverize and be powdery, cross 200 mesh sieves, mix, medicated powder, incapsulate and process capsule.
During treatment, oral, each was once taken about 5g at every turn and (pressed the medicated powder Mass Calculation) sooner or later every day, and 15 days is a course of treatment, and can cure general 2～5 courses of treatment.
A kind of Chinese medicine preparation of treating chronic pelvic inflammatory disease of embodiment 2 preparations
Prescription is: Radix Angelicae Sinensis 22g, Poria 22g, Herba Leonuri 28g, Rhizoma Et Radix Notopterygii 23g, Flos Carthami 18g, Sanguis Draxonis 18g, Radix Angelicae Dahuricae 23g, Rhizoma Atractylodis Macrocephalae 23g, Radix Paeoniae Rubra 12g, Herba Taxilli 12g, Cortex Acanthopancis 18g, windproof 13g, Radix Astragali 8g, Radix Ginseng 8g, Rhizoma Pinelliae 13g, Radix Angelicae Pubescentis 13g.
Method for preparing is: get each crude drug, pulverize and be powdery, cross 200 mesh sieves, mix, medicated powder, process tablet.
A kind of Chinese medicine preparation of treating chronic pelvic inflammatory disease of embodiment 3 preparations
Prescription is: Radix Angelicae Sinensis 28g, Poria 28g, Herba Leonuri 22g, Rhizoma Et Radix Notopterygii 18g, Flos Carthami 23g, Sanguis Draxonis 23g, Radix Angelicae Dahuricae 18g, Rhizoma Atractylodis Macrocephalae 18g, Radix Paeoniae Rubra 18g, Herba Taxilli 18g, Cortex Acanthopancis 12g, windproof 8g, Radix Astragali 13g, Radix Ginseng 13g, Rhizoma Pinelliae 8g, Radix Angelicae Pubescentis 8g.
Method for preparing is: get each crude drug, pulverize and be powdery, cross 200 mesh sieves, mix, medicated powder, promptly get.
A kind of Chinese medicine preparation of treating chronic pelvic inflammatory disease of embodiment 4 preparations
Prescription is: Radix Angelicae Sinensis 20g, Poria 30g, Herba Leonuri 20g, Rhizoma Et Radix Notopterygii 25g, Flos Carthami 15g, Sanguis Draxonis 25g, Radix Angelicae Dahuricae 15g, Rhizoma Atractylodis Macrocephalae 25g, Radix Paeoniae Rubra 10g, Herba Taxilli 20g, Cortex Acanthopancis 10g, windproof 15g, Radix Astragali 5g, Radix Ginseng 15g, Rhizoma Pinelliae 5g, Radix Angelicae Pubescentis 15g.
Method for preparing is: get each crude drug, pulverize and be powdery, cross 200 mesh sieves, mix, medicated powder, add conventional substrate system
Method for preparing is: get each crude drug, pulverize and be powdery, cross 200 mesh sieves, mix, medicated powder, add conventional substrate and process pill.
A kind of Chinese medicine preparation of treating chronic pelvic inflammatory disease of embodiment 5 preparations
Prescription is: Radix Angelicae Sinensis 30g, Poria 20g, Herba Leonuri 30g, Rhizoma Et Radix Notopterygii 15g, Flos Carthami 25g, Sanguis Draxonis 15g, Radix Angelicae Dahuricae 25g, Rhizoma Atractylodis Macrocephalae 15g, Radix Paeoniae Rubra 20g, Herba Taxilli 10g, Cortex Acanthopancis 20g, windproof 5g, Radix Astragali 15g, Radix Ginseng 5g, Rhizoma Pinelliae 15g, Radix Angelicae Pubescentis 5g.
Method for preparing is: get each crude drug, pulverize and be powdery, cross 200 mesh sieves, mix, medicated powder, when taking, hot water is taken after mixing it with water.
Clinical data:
Patient's data: 126 routine patients all suffer from chronic pelvic inflammatory disease, and wherein between 20～45 years old age, average 31 years old, the course of disease was the longest 6 years, the shortest person half a year.
Diagnostic criteria:
(1) symptom: pain is weighed down in the hypogastric region one or both sides of showing effect repeatedly and waist bones of the body portion aches, and be everlasting menstruation front and back, sexual intercourse and tired postemphasis are accompanied menoxenia and leucorrhoea grow in quantity, abnormal flavour is arranged, and fallopian tube can cause infertile when suddenly connecting obstruction.
(2) sign: cervix uteri is praised pain, and the uterus is the position, back more, suddenly connects fixed or movable limited and tenderness; Can lay one's hand in the one or both sides, uterus and streak thing or touch enclosed mass, and with tenderness; During inflammation of pelvic connective tissue, the one or both sides, uterus have that lamellar thickens, tenderness.
(3) ultrasonic examination prompting: pelvic hydrops, inflammatory mass, bilateral or one-sided adnexa thicken.
(4) lab testing: can have leukocyte and neutrophilic granulocyte to increase or normally.
Therapeutic modality: adopt medicine of the present invention to treat (medicine of embodiment 1 preparation), oral, every day, each once took 5g (pressing crude drug medicated powder Mass Calculation) at every turn sooner or later, and 15 days is a course of treatment, and menstrual phase is suspended usefulness.Treat observe the curative effect after two months.
The therapeutic evaluation standard:
Cure: cardinal symptom, sign, the sharp inspection of woman all recover normal, and ultrasonic examination prompting inflammatory mass or inflammatory exudate all disappear, and it is normal that bilateral or one-sided adnexa recover, and do not have recurrence after the drug withdrawal in 6 months.
Produce effects: cardinal symptom disappears, and gynecologial examination has clear improvement, and ultrasonic examination prompting pelvic hydrops or empyema reduce or disappear, and bilateral or one-sided fallopian tube increase slightly and obviously alleviate, and inflammatory mass or inflammatory exudate all dwindle or disappear.
Invalid: the local nothing of clinical symptoms and gynecologial examination is improved, and ultrasonic prompting inflammatory mass or inflammatory exudate do not have obvious improvement.
The result: treatment among the 126 routine patients, is cured 62 examples after two months, produce effects 53 examples, and invalid 11 examples, cure rate is 49.2%, and total effective rate is 91.3%; The patient all has no adverse reaction during the treatment.
Claims (5)
1. a Chinese medicine preparation of treating chronic pelvic inflammatory disease is characterized in that: be made up of following crude drug: Radix Angelicae Sinensis 20～30g, Poria 20～30g, Herba Leonuri 20～30g, Rhizoma Et Radix Notopterygii 15～25g; Flos Carthami 15～25g, Sanguis Draxonis 15～25g, the Radix Angelicae Dahuricae 15～25g, the Rhizoma Atractylodis Macrocephalae 15～25g; Radix Paeoniae Rubra 10～20g, Herba Taxilli 10～20g, Cortex Acanthopancis 10～20g, windproof 5～15g; The Radix Astragali 5～15g, Radix Ginseng 5～15g, the Rhizoma Pinelliae 5～15g, Radix Angelicae Pubescentis 5～15g.
2. a kind of Chinese medicine preparation of treating chronic pelvic inflammatory disease according to claim 1 is characterized in that: be made up of following crude drug: Radix Angelicae Sinensis 25g, Poria 25g, Herba Leonuri 25g, Rhizoma Et Radix Notopterygii 20g; Flos Carthami 20g, Sanguis Draxonis 20g, Radix Angelicae Dahuricae 20g, Rhizoma Atractylodis Macrocephalae 20g; Radix Paeoniae Rubra 15g, Herba Taxilli 15g, Cortex Acanthopancis 15g, windproof 10g; Radix Astragali 10g, Radix Ginseng 10g, Rhizoma Pinelliae 10g, Radix Angelicae Pubescentis 10g.
3. a kind of Chinese medicine preparation of treating chronic pelvic inflammatory disease according to claim 1 is characterized in that: be made up of following crude drug: Radix Angelicae Sinensis 22g, Poria 22g, Herba Leonuri 28g, Rhizoma Et Radix Notopterygii 23g; Flos Carthami 18g, Sanguis Draxonis 18g, Radix Angelicae Dahuricae 23g, Rhizoma Atractylodis Macrocephalae 23g; Radix Paeoniae Rubra 12g, Herba Taxilli 12g, Cortex Acanthopancis 18g, windproof 13g; Radix Astragali 8g, Radix Ginseng 8g, Rhizoma Pinelliae 13g, Radix Angelicae Pubescentis 13g.
4. a kind of Chinese medicine preparation of treating chronic pelvic inflammatory disease according to claim 1 is characterized in that: be made up of following crude drug: Radix Angelicae Sinensis 28g, Poria 28g, Herba Leonuri 22g, Rhizoma Et Radix Notopterygii 18g; Flos Carthami 23g, Sanguis Draxonis 23g, Radix Angelicae Dahuricae 18g, Rhizoma Atractylodis Macrocephalae 18g; Radix Paeoniae Rubra 18g, Herba Taxilli 18g, Cortex Acanthopancis 12g, windproof 8g; Radix Astragali 13g, Radix Ginseng 13g, Rhizoma Pinelliae 8g, Radix Angelicae Pubescentis 8g.
5. the method for preparing of the Chinese medicine preparation of each described treatment chronic pelvic inflammatory disease in the claim 1～4 is characterized in that: get each crude drug, pulverize and be powdery, cross 200 mesh sieves, mix, promptly get.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 201210022841 CN102526399B (en) | 2012-02-02 | 2012-02-02 | Chinese medicine preparation for treating chronic pelvic inflammation |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 201210022841 CN102526399B (en) | 2012-02-02 | 2012-02-02 | Chinese medicine preparation for treating chronic pelvic inflammation |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN102526399A true CN102526399A (en) | 2012-07-04 |
| CN102526399B CN102526399B (en) | 2013-10-16 |
Family
ID=46335219
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 201210022841 Active CN102526399B (en) | 2012-02-02 | 2012-02-02 | Chinese medicine preparation for treating chronic pelvic inflammation |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102526399B (en) |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101518635A (en) * | 2008-02-28 | 2009-09-02 | 北京中泰天和科技有限公司 | Traditional Chinese medicine for treating gynecological inflammation, capable of removing heat and drying damp, activating blood and dissolving stasis |
-
2012
- 2012-02-02 CN CN 201210022841 patent/CN102526399B/en active Active
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101518635A (en) * | 2008-02-28 | 2009-09-02 | 北京中泰天和科技有限公司 | Traditional Chinese medicine for treating gynecological inflammation, capable of removing heat and drying damp, activating blood and dissolving stasis |
Non-Patent Citations (2)
| Title |
|---|
| 周俊: "浅谈妇科炎症的中药治疗", 《浙江中西医结合杂志》 * |
| 易宏英: "中医药治疗慢性***的临床研究进展", 《陕西中医学院学报》 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN102526399B (en) | 2013-10-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102370725A (en) | Traditional Chinese medicine compound preparation for treating chronic pelvic inflammation and preparation method thereof | |
| CN101780160B (en) | Traditional Chinese medicine preparation for treating gynecological disease and preparation method thereof | |
| CN104857478A (en) | Medical composition for treating hysteromyoma and preparation method of medical composition | |
| CN104474473B (en) | A kind of Chinese medicine composition for treating gynaecological imflammation and preparation method thereof | |
| CN102671135A (en) | Chinese medicinal composition for treating ovarian cyst, and preparation method thereof | |
| CN102671141A (en) | Chinese medicine for curing hyperplasia of mammary glands | |
| CN102526342B (en) | Traditional Chinese medicine preparation for treating chronic cervicitis | |
| CN103157055B (en) | Traditional Chinese medicine preparation for treating hyperplasia of mammary glands | |
| CN103893671A (en) | Pharmaceutical composition for treating hysteromyoma | |
| CN103585573B (en) | Oral medicine for treating hysteromyoma | |
| CN101837099B (en) | Chinese medicinal composition for curing intermenstrual bleeding and preparation method thereof | |
| CN103860882A (en) | Medicinal preparation for treating chronic cervicitis | |
| CN102526399B (en) | Chinese medicine preparation for treating chronic pelvic inflammation | |
| CN103263650A (en) | Chinese medicament for conditioning female menstruation | |
| CN103071018A (en) | Traditional Chinese medicine preparation for treating early habitual abortion | |
| CN102755422B (en) | Health care product for relieving dysmenorrheal | |
| CN103550668B (en) | A kind of Chinese medicine for the treatment of gynecological's habitual abortion disease | |
| CN101850101B (en) | Chinese medicinal composition for treating metrostaxis and preparation method thereof | |
| CN104644996A (en) | Medicine composition for treating hyperplasia of mammary glands and application thereof | |
| CN103830566B (en) | A kind of pharmaceutical preparation for the treatment of chronic pelvic inflammatory disease | |
| CN103341025A (en) | Traditional Chinese medicine composition for treating premature ejaculation | |
| CN102727808B (en) | Drug for rapidly treating dysmenorrheal and abdomen mass | |
| CN100475251C (en) | Medication for treating chronic appendages inflammation, and preparation method thereof | |
| CN101972306B (en) | Chinese medicinal capsule for treating chronic pelvic inflammatory disease | |
| CN103977214A (en) | External preparation for treating chronic pelvic inflammatory disease |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| ASS | Succession or assignment of patent right |
Owner name: NANTONG WEEK TOURISM DEVELOPMENT CO., LTD. Free format text: FORMER OWNER: LI KUN Effective date: 20140820 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 250031 JINAN, SHANDONG PROVINCE TO: 226121 NANTONG, JIANGSU PROVINCE |
|
| TR01 | Transfer of patent right |
Effective date of registration: 20140820 Address after: 226121 Jiangsu Province Haimen Nantong market three factory town Road No. 79 Patentee after: Nantong seven Tourism Development Co., Ltd. Address before: Reproductive health care department of the 250031 Affiliated Hospital of Shandong District of Ji'nan City flyover shadowless Road No. 38 Shandong Academy of Medical Sciences Patentee before: Li Kun |
|
| TR01 | Transfer of patent right |
Effective date of registration: 20190412 Address after: 511400 Room 1424, 12 Bowang Street, Nancun Town, Panyu District, Guangzhou City, Guangdong Province Patentee after: Zibo Blue Ribbon Health Management Co., Ltd. Guangzhou Branch Address before: 226121 79 vegetable market road, three factory town, Haimen, Nantong, Jiangsu Patentee before: Nantong seven Tourism Development Co., Ltd. |
|
| TR01 | Transfer of patent right |